Chemistry and Biodiversity (2020)
Update date:2022-08-02
Topics:
Patel, Harun M.
Palkar, Mahesh
Karpoormath, Rajshekhar
Drug resistance tuberculosis is one of the challenging tasks that dictates the desperate need for the development of new antitubercular agents which operate via novel modes of action. Here, we are reporting on 4-aminoquinazolines as M. tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmUMTB) inhibitors to overcome the problem of the MDR-TB. Amongst the synthesized compounds, two of them were observed to be the effective compounds of the series (IC50=6.4 μM (H37Rv), MIC=25 μM (MDR-TB) and IC50=2.9 μM (H37Rv), MIC=6.25 μM (MDR-TB), respectively).
View MoreContact:+86-535-8888888
Address:No.161 Haishi Rd.
Hangzhou Donglou Bio-nutrient Co., Ltd.
Contact:+86-571-82225795,13967112289
Address:Louta Town, Xiaoshan,Hangzhou,Zhejiang
Contact:852-27701081
Address:Room 2509, New Tech Plaza, 34 Tai Yau St., San Po Kong, HK
Jinan Hongfangde Pharmatech Co.LTD
Contact:0531-88870908
Address:F Bldg,750#,Shunhua Rd,New&High-tech Zone,Jinan,Shandong,China 250101
Hebei Lead Bio-Chemicals Co., Ltd.
website:http://www.ldbiochem.com
Contact:+86-311-87826503
Address:481, Heping West Road, Shijiazhuang,China
Doi:10.1016/j.tetlet.2016.11.081
(2017)Doi:10.1016/j.ejmech.2019.06.027
(2019)Doi:10.1246/bcsj.37.204
(1964)Doi:10.1002/hlca.19980810304
(1998)Doi:10.1002/pola.27417
(2014)Doi:10.1016/S0040-4039(00)95814-3
(1987)